Ocugen, Inc. Gains 23.76%

Mon, May 03, 2021 at 05:30 PM
Ocugen, Inc. Gains 23.76%

Ocugen, Inc. (OCGN:NASDAQ) shot up at $15.68, representing a gain of 23.8%. On Fri, Apr 30, 2021, OCGN:NASDAQ hit a New 2-Week High of $12.67. The stock appeared on our News Catalysts scanner on Mon, May 03, 2021 at 04:51 PM in the 'INVESTOR UPDATE' category. From Fri, Apr 16, 2021, the stock recorded 70.00% Up Days and 63.64% Green Days

The stock spiked on Fri, Apr 23, 2021 at $13.65 with a volume of 492M+.

About Ocugen, Inc. (OCGN:NASDAQ)

Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Its product candidate includes OCU200 and OCU300 to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (AMD).

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.